Harmony Biosciences Holdings Inc Receivables Turnover Ratio (HRMY), from the third quarter 2026 to the third quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Harmony Biosciences Holdings inc   (NASDAQ: HRMY)
 

Harmony Biosciences Holdings Inc Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Harmony Biosciences Holdings Inc 's ability to collect accounts receivable sequentially worsen to 8.93, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Harmony Biosciences Holdings Inc 's Accounts Receivable average collection period in the Sep 30 2026 quarter, has increased to 41 days, from 40 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 132 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2026 from 1232 to 1368.

What is Receivable Turnover Ratio?
What is Harmony Biosciences Holdings Inc Selling?


What is Receivable Turnover Ratio?





HRMY Receivables Turnover Ratio (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Receivable Change 26.91 % 19.37 % 2.13 % 16.56 % 23.5 %
Y / Y Revenue Change 12.61 % 30.42 % 16.95 % 21.49 % 28.9 %
Receivable Turnover Ratio (TTM) 8.93 9.22 9.02 8.76 8.62
HRMY's Total Ranking # 1368 # 1232 # 966 # 1355 #
Accounts Receivable average collection period days 41 40 40 42 42
Seq. Receivable Change 15.09 % 2.56 % 11.81 % -3.84 % 8.25 %
Seq. Revenue Change 2.92 % 21.6 % -12.38 % 2.69 % 19.2 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 49
Healthcare Sector # 133
Overall Market # 1368

Receivable Turnover Ratio Statistics
High Average Low
11.17 8.93 5.72
(Sep 30 2020)   (Jun 30 2021)






Financial Statements
Harmony Biosciences Holdings Inc 's Accounts Receivable $ 128 Millions Visit HRMY's Balance sheet
Harmony Biosciences Holdings Inc 's Sales TTM $ 990 Millions Visit HRMY's Income Statement
Sources of HRMY's Revenues Visit HRMY's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
HRMY's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
HRMY's Growth Rates HRMY's Roa HRMY's Inventory Turnover Ratio HRMY's Dividend Comparisons
HRMY's Profitability Ratios HRMY's Roi HRMY's Asset Turnover Ratio HRMY's Dividend Growth
HRMY's Valuation Ratios HRMY's Roe HRMY's Financial Strength Ratios HRMY's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Receivable at quarter ending Sep 30 2026
Arvinas Inc   20.06 $ 275.300  Millions$ 13.725  Millions
Biogen Inc   15.19 $ 10,297.300  Millions$ 677.900  Millions
Corcept Therapeutics Inc  13.44 $ 963.647  Millions$ 71.710  Millions
Chemed Corporation  12.65 $ 2,661.041  Millions$ 210.387  Millions
Caredx Inc   11.75 $ 497.396  Millions$ 42.330  Millions
Teladoc Health Inc   11.50 $ 2,468.143  Millions$ 214.604  Millions
Iqvia Holdings Inc   10.43 $ 17,311.000  Millions$ 1,659.500  Millions
Encompass Health Corporation  9.41 $ 6,338.100  Millions$ 673.625  Millions
Bausch Health Companies Inc   9.15 $ 11,113.000  Millions$ 1,215.000  Millions
Pacs Group Inc   8.88 $ 5,705.049  Millions$ 642.729  Millions
Axogen inc   8.71 $ 266.926  Millions$ 30.654  Millions
Ensign Group Inc  8.62 $ 5,674.305  Millions$ 658.477  Millions
Pediatrix Medical Group Inc   8.57 $ 1,959.124  Millions$ 228.471  Millions
Tenet Healthcare Corp  8.54 $ 22,154.000  Millions$ 2,593.250  Millions
Brightspring Health Services Inc   8.50 $ 9,479.144  Millions$ 1,114.763  Millions
Sotera Health Company  8.49 $ 1,230.250  Millions$ 144.974  Millions
Tactile Systems Technology Inc   8.23 $ 357.176  Millions$ 43.385  Millions
Penumbra Inc  8.22 $ 1,560.334  Millions$ 189.735  Millions
Inspire Medical Systems inc   8.15 $ 882.194  Millions$ 108.207  Millions
Adapthealth Corp   8.14 $ 3,152.043  Millions$ 387.280  Millions
Rhythm Pharmaceuticals Inc   8.03 $ 280.748  Millions$ 34.950  Millions
Alphatec Holdings Inc   7.91 $ 839.652  Millions$ 106.153  Millions
Exelixis Inc   7.89 $ 2,496.861  Millions$ 316.636  Millions
Henry Schein Inc   7.84 $ 13,734.000  Millions$ 1,752.000  Millions
Idexx Laboratories Inc  7.78 $ 4,663.675  Millions$ 599.701  Millions
Madrigal Pharmaceuticals Inc   7.70 $ 1,427.940  Millions$ 185.380  Millions
Pulmonx Corporation  7.56 $ 89.176  Millions$ 11.791  Millions
Merit Medical Systems Inc  7.53 $ 1,612.236  Millions$ 214.065  Millions
Cerus Corporation  7.48 $ 226.798  Millions$ 30.308  Millions
Insmed Inc  7.45 $ 1,479.040  Millions$ 198.502  Millions

Date modified: 2026-11-05T10:38:16+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.